- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
**Consolidated Financial Summary for Sanofi Consumer Healthcare India Limited**
Revenue from operations for the year ended December 31, 2024, stood at ₹7,245 crore, reflecting robust growth compared to ₹5,554 crore in the previous year, marking an increase of approximately 30.5%. This growth can be attributed to enhanced product demand, successful market expansion, and improved operational efficiencies following the demerger from Sanofi India Limited.
Net profit for the year reached ₹1,810 crore, up from ₹1,649 crore year-on-year, representing a growth of 9.8%. The Earnings Per Share (EPS) was reported at ₹78.59, indicating strong profitability driven by effective cost management strategies, despite incurring exceptional expenses related to product recalls and demerger costs.
Operational costs totaled ₹4,623 crore, up from ₹3,384 crore, primarily due to increased employee benefits expenses and costs tied to the transition of the Consumer Healthcare business. This reflects strategic investments aimed at long-term operational efficiencies.
The consolidated balance sheet reveals total assets of ₹4,313 crore, demonstrating a solid financial foundation. Equity increased to ₹2,730 crore, supported by enhanced reserves post-demerger, which positions the company favorably for future growth opportunities.
Strategically, the company appears focused on maintaining quality across its product lines while navigating recent operational challenges. Market sentiment remains positive as the organization leverages its strengthened position in the consumer healthcare segment.
Investors may consider a buy insight given the continued revenue growth, improving profit margins, and strategic expansions that indicate potential for sustained performance. However, caution is advised due to the ongoing impacts from product recalls and market realignment post-demerger.
All announcements from Sanofi Consumer Healthcare India Limited